International Society for Diseases of the Esophagus consensus on management of the failed fundoplication
- PMID: 39444316
- PMCID: PMC11605648
- DOI: 10.1093/dote/doae090
International Society for Diseases of the Esophagus consensus on management of the failed fundoplication
Abstract
Fundoplication is a durable, effective, and well-accepted treatment for gastroesophageal reflux disease. Nonetheless, troublesome postoperative symptoms do occasionally occur with management varying widely among centers. In an attempt to standardize definition and management of postfundoplication symptoms, a panel of international experts convened by the Guidelines Committee of the International Society for Diseases of the Esophagus devised a list of 33 statements across 5 domains through a Delphi approach, with at least 80% agreement to establish consensus. Eight statements were endorsed for the domain of Definitions, four for the domain of Investigations, nine for Dysphagia, nine for Heartburn, and four for Revisional surgery. This consensus defined as the treatment goal of fundoplication the resolution of symptoms rather than normalization of physiology or anatomy. Required investigations of all symptomatic postfundoplication patients were outlined. Further management was standardized by patients' symptomatology. The appropriateness of revisional fundoplication and the techniques thereof were described and the role of revisional surgery for therapies other than fundoplication were assessed. Fundoplication remains a frequently-performed operation, and this is the first international consensus on the management of various postfundoplication problems.
Keywords: consensus; evidence-based medicine; fundoplication; gastroesophageal reflux disease; heartburn; regurgitation.
© The Author(s) 2024. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus.
References
-
- Slater B J, Collings A, Dirks R et al. Multi-society consensus conference and guideline on the treatment of gastroesophageal reflux disease (GERD). Surg Endosc 2023; 37(2): 781–806. - PubMed
-
- Eusebi L H, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford A C. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut 2018; 67(3): 430–40. - PubMed
-
- Savarino E, Zentilin P, Tutuian R et al. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol 2008; 103(11): 2685–93. - PubMed
-
- Clayton S B, Rife C C, Singh E R, Kalbfleisch J H, Castell D O. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing. Dis Esophagus 2012; 25(8): 682–6. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
